Acute fascioliasis—clinical and epidemiological features of four patients in Chile

Mas-Coma, 2004, Human fascioliasis, 305 2007 Keiser, 2009, Food-borne trematodiases, Clin Microbiol Rev, 22, 466, 10.1128/CMR.00012-09 Graham, 2001, Imported Fasciola hepatica infection in the United States and treatment with triclabendazole, Clin Infect Dis, 33, 1, 10.1086/320870 Noyer, 2002, Hypereosinophilia and liver mass in an immigrant, Am J Trop Med Hyg, 66, 774, 10.4269/ajtmh.2002.66.774 Kang, 2008, Fasciola hepatica in a New Zealander traveler, J Travel Med, 15, 196, 10.1111/j.1708-8305.2008.00207.x Chand, 2009, Imported human fascioliasis, United Kingdom, Emerg Infect Dis, 15, 1876, 10.3201/eid1511.090511 Arjona, 1995, Fascioliasis in developed countries: a review of classic and aberrant forms of the disease, Medicine (Baltimore), 74, 13, 10.1097/00005792-199501000-00002 Aksoy, 2005, Infection with Fasciola hepatica, Clin Microbiol Infect, 11, 859, 10.1111/j.1469-0691.2005.01254.x Marcos, 2008, Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis, Am J Trop Med Hyg, 78, 222, 10.4269/ajtmh.2008.78.222 MacLean, 2005, Liver, lung and intestinal fluke infections, 1349 Marcos, 2008, Update on hepatobiliary flukes: fasciolasis, opisthorchiasis and clonorchiasis, Curr Opin Infect Dis, 21, 523, 10.1097/QCO.0b013e32830f9818 Behar, 2009, Hepatic fascioliasis at a London hospital—the importance of recognising typical radiological features to avoid a delay in diagnosis, Br J Radiol, 82, e189, 10.1259/bjr/78759407 Cerri, 1984, Hepatosplenic Schistosomiasis mansoni: ultrasound manifestations, Radiology, 153, 777, 10.1148/radiology.153.3.6387793 Agarwal, 2009, Budd—Chiari syndrome owing to liver hydatid disease: case report and review of the literature, Ann Trop Paediatr, 29, 301, 10.1179/027249309X12547917869087 Apt, 1993, Prevalence of fascioliasis in humans, horses, pigs, and wild rabbits in 3 Chilean provinces, Bol Oficina Sanit Panam, 115, 405 Cosme, 2001, Fasciolasis hepatobiliar. Estudio de una serie de 37 pacientes, Gastroenterol Hepatol, 24, 375, 10.1016/S0210-5705(01)70204-X Hassan, 1989, Cross-reactions in immunodiagnosis of patients infected with Schistosoma Fasciola and Heterophyes using ELISA, J Egypt Soc Parasitol, 19, 845 Romasanta, 2003, Diagnosis of parasitic zoonoses by immunoenzymatic assays—analysis of cross-reactivity among the excretory/secretory antigens of Fasciola hepatica Toxocara canis, and Ascaris suum, Immunol Invest, 32, 131, 10.1081/IMM-120022974 Shehab, 1999, Circulating antibodies and antigens correlate with egg counts in human fascioliasis, Trop Med Int Health, 4, 691, 10.1046/j.1365-3156.1999.00466.x Mailles, 2006, Commercial watercress as an emerging source of fascioliasis in Northern France in 2002: results from an outbreak investigation, Epidemiol Infect, 134, 942, 10.1017/S095026880600611X Mas-Coma, 2009, Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control, Adv Parasitol, 69, 41, 10.1016/S0065-308X(09)69002-3 Alcaíno, 1993, Epidemiología de la fasciolasis hepática en la VII Región Chile, Parasitol Día, 17, 99 Apt, 1995, Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response, Am J Trop Med Hyg, 52, 532, 10.4269/ajtmh.1995.52.532 Millán, 2000, The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection, Am J Trop Med Hyg, 63, 264, 10.4269/ajtmh.2000.63.264 Jave, 1999, Tratamiento de la fasciolasis hepática humana con triclabendazole, Rev Gastroenterol Perú, 19, 216